Phaseline

Companies › SetPoint Medical

SetPoint Medical: clinical trials, targets and expected readouts

1 active drug program in 1 registered trial: 1 Phase 3; Immunology; next expected readout Oct 2027.

Open in Phaseline: competitors, likelihood bands and readouts Company report

Programs

DrugTargetHighest phaseConditionsNext expected readout
SetPoint System (vagus nerve stimulator)
Vagus nerve stimulation
–Phase 3Rheumatoid ArthritisOct 2027

Trials

Registry idDrugPhaseConditionsAreaExpected readout
NCT04539964SetPoint System (vagus nerve stimulator)Phase 3Rheumatoid ArthritisImmunologyOct 2027

Targets

No annotated target.

Companies with the same targets

–

Companies built like this

Pharvaris Netherlands AUG Therapeutics Lynk Pharmaceuticals Fujian Mindong Rejuvenation Pharmaceutical Jiangsu Genscend Biopharmaceutical

Pipelines of the same shape: areas, drug types, target families, stage and cash runway.

Programs group the company's trials by drug; the target and mechanism come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood, shown as a band with its track record, is in the app.